Avisi Technologies News Today

SAN DIEGO — Surgeons should optimize their treatment of dysphotopsias based on each patient’s natural ability for neuroadaptation, according to a speaker here.

Take note of these November and December announcements, including a $65 Series A for Penn gene-editing spinout iECURE. Plus, the Center for Diagnostics Discovery is launching in Horsham.